Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Charles Daley

Concepts (471)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mycobacterium Infections, Nontuberculous
100
2026
366
17.930
 Why?
Mycobacterium avium-intracellulare Infection
29
2026
63
9.600
 Why?
Mycobacterium abscessus
43
2026
118
9.190
 Why?
Mycobacterium avium Complex
44
2026
88
8.650
 Why?
Nontuberculous Mycobacteria
54
2026
208
7.810
 Why?
Lung Diseases
47
2026
787
7.740
 Why?
Anti-Bacterial Agents
69
2026
1907
6.620
 Why?
Antitubercular Agents
39
2025
215
5.300
 Why?
Tuberculosis
33
2025
291
4.910
 Why?
Tuberculosis, Pulmonary
26
2025
131
4.380
 Why?
Tuberculosis, Multidrug-Resistant
14
2025
50
3.470
 Why?
Amikacin
19
2026
28
3.440
 Why?
Mycobacterium Infections
12
2019
61
3.170
 Why?
Mycobacterium
16
2026
116
2.880
 Why?
Mycobacterium kansasii
10
2020
14
2.870
 Why?
Bronchiectasis
19
2026
112
2.800
 Why?
Cystic Fibrosis
22
2025
1158
2.640
 Why?
Mycobacterium tuberculosis
28
2025
334
2.610
 Why?
Macrolides
15
2023
69
2.270
 Why?
Interferon-gamma Release Tests
7
2025
32
2.000
 Why?
Drug Resistance, Bacterial
21
2023
196
1.870
 Why?
Microbial Sensitivity Tests
29
2026
370
1.700
 Why?
Sputum
25
2020
308
1.530
 Why?
Disease Outbreaks
7
2025
422
1.410
 Why?
Humans
205
2026
144759
1.310
 Why?
Latent Tuberculosis
8
2017
71
1.210
 Why?
Pneumonia, Bacterial
6
2017
113
1.180
 Why?
Drug Therapy, Combination
22
2026
1047
1.140
 Why?
AIDS-Related Opportunistic Infections
4
2016
130
1.110
 Why?
Boron Compounds
2
2026
29
1.110
 Why?
Antibiotics, Antitubercular
9
2021
35
1.060
 Why?
Clofazimine
4
2021
15
1.060
 Why?
Rifampin
14
2024
82
1.050
 Why?
Ethambutol
11
2026
27
1.020
 Why?
Clarithromycin
14
2026
25
0.960
 Why?
Pneumonia
5
2023
631
0.950
 Why?
Tetracyclines
1
2025
17
0.930
 Why?
Patient Reported Outcome Measures
2
2026
488
0.850
 Why?
Treatment Outcome
35
2026
11679
0.840
 Why?
Oxazolidinones
3
2013
17
0.830
 Why?
Acetamides
3
2013
37
0.810
 Why?
HIV Infections
15
2022
3154
0.780
 Why?
Global Health
8
2018
401
0.780
 Why?
Fatigue
1
2025
366
0.770
 Why?
Aged
57
2026
25913
0.770
 Why?
Tuberculin Test
6
2016
36
0.730
 Why?
Equipment Contamination
2
2019
71
0.690
 Why?
Azithromycin
7
2026
104
0.690
 Why?
Middle Aged
64
2026
35875
0.680
 Why?
Professional Practice Gaps
1
2020
15
0.650
 Why?
Imipenem
7
2024
16
0.630
 Why?
beta-Lactams
3
2026
32
0.620
 Why?
Adult
57
2026
40449
0.610
 Why?
Disease Management
4
2021
645
0.600
 Why?
Female
82
2026
78271
0.600
 Why?
Male
82
2026
72315
0.590
 Why?
San Francisco
10
2014
60
0.560
 Why?
Practice Guidelines as Topic
9
2026
1560
0.550
 Why?
Molecular Epidemiology
4
2006
73
0.550
 Why?
Administration, Inhalation
7
2026
574
0.520
 Why?
Algorithms
1
2025
1837
0.510
 Why?
Health Care Sector
2
2013
26
0.490
 Why?
Linezolid
5
2026
25
0.490
 Why?
Recurrence
11
2025
1135
0.480
 Why?
Extensively Drug-Resistant Tuberculosis
2
2013
6
0.480
 Why?
beta-Lactamase Inhibitors
6
2026
9
0.470
 Why?
Drug Resistance, Multiple, Bacterial
4
2019
81
0.470
 Why?
Nebramycin
2
2025
2
0.470
 Why?
United States
32
2025
15966
0.470
 Why?
Lung
16
2024
4109
0.450
 Why?
Phylogeny
5
2021
1016
0.440
 Why?
Genome, Bacterial
5
2021
155
0.440
 Why?
World Health Organization
3
2024
105
0.440
 Why?
Retrospective Studies
29
2025
17066
0.420
 Why?
Organ Transplantation
2
2024
247
0.410
 Why?
Drug Synergism
4
2024
357
0.410
 Why?
Communicable Disease Control
1
2014
86
0.400
 Why?
Sex Factors
1
2019
2112
0.390
 Why?
Serologic Tests
1
2012
53
0.380
 Why?
Quality of Life
8
2026
3185
0.370
 Why?
Professional Practice
1
2012
57
0.370
 Why?
Rifabutin
2
2012
7
0.350
 Why?
Opportunistic Infections
1
2011
45
0.350
 Why?
Antibiotic Prophylaxis
1
2012
129
0.340
 Why?
Pyrazinamide
4
2021
16
0.340
 Why?
Liposomes
2
2026
250
0.330
 Why?
Cefoxitin
4
2026
8
0.320
 Why?
Drug Administration Schedule
8
2025
779
0.320
 Why?
Occupational Health
1
2013
209
0.310
 Why?
Aged, 80 and over
15
2025
8265
0.300
 Why?
Occupational Exposure
1
2013
354
0.290
 Why?
Cross Infection
2
2025
262
0.290
 Why?
Disease Progression
8
2026
2847
0.290
 Why?
Incidence
10
2019
2879
0.290
 Why?
Diarylquinolines
3
2025
16
0.280
 Why?
Mass Screening
3
2016
1347
0.280
 Why?
Cardiac Surgical Procedures
3
2019
609
0.270
 Why?
Dose-Response Relationship, Drug
6
2026
2027
0.270
 Why?
Double-Blind Method
5
2026
2029
0.270
 Why?
Antigens, Bacterial
5
2012
125
0.270
 Why?
Directly Observed Therapy
2
2005
15
0.270
 Why?
Europe
3
2025
412
0.260
 Why?
Cefuroxime
2
2024
5
0.260
 Why?
Carcinoma, Squamous Cell
1
2012
641
0.260
 Why?
Prospective Studies
16
2025
7990
0.260
 Why?
Tuberculosis, Pleural
2
2003
7
0.260
 Why?
Health Personnel
3
2014
748
0.250
 Why?
Treatment Failure
5
2026
365
0.240
 Why?
Cephalosporins
2
2024
47
0.240
 Why?
Morbidity
2
2019
323
0.240
 Why?
Tomography, X-Ray Computed
9
2020
2730
0.240
 Why?
Suspensions
1
2026
29
0.240
 Why?
Genomics
4
2021
834
0.230
 Why?
Administration, Oral
4
2025
847
0.230
 Why?
Phage Therapy
1
2025
17
0.220
 Why?
ROC Curve
4
2020
614
0.220
 Why?
Oxazepines
2
2025
5
0.220
 Why?
Diagnostic Tests, Routine
2
2019
108
0.220
 Why?
Antibodies, Monoclonal
1
2012
1519
0.220
 Why?
Benzoxazoles
2
2025
20
0.220
 Why?
Peptidyl Transferases
2
2024
8
0.220
 Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2025
46
0.220
 Why?
Mutation
5
2019
4089
0.220
 Why?
Disease Transmission, Infectious
1
2005
69
0.220
 Why?
Water Microbiology
1
2005
90
0.210
 Why?
DNA Fingerprinting
1
2004
32
0.210
 Why?
Contact Tracing
1
2004
26
0.210
 Why?
Arizona
1
2024
81
0.210
 Why?
Boronic Acids
1
2024
37
0.210
 Why?
Alveolitis, Extrinsic Allergic
1
2005
93
0.210
 Why?
Research
2
2018
431
0.210
 Why?
Adolescent
19
2025
22428
0.210
 Why?
Self Administration
1
2004
124
0.200
 Why?
DNA, Bacterial
3
2021
342
0.200
 Why?
Risk Factors
9
2019
10779
0.200
 Why?
Medical Tourism
1
2023
9
0.200
 Why?
Mexico
1
2024
233
0.200
 Why?
Biomedical Research
5
2020
710
0.200
 Why?
Time Factors
8
2026
7173
0.200
 Why?
Colorado
5
2024
4564
0.200
 Why?
London
1
2023
46
0.190
 Why?
Biomarkers
3
2020
4271
0.190
 Why?
Leprostatic Agents
1
2022
6
0.190
 Why?
Stem Cell Transplantation
1
2024
191
0.190
 Why?
Clinical Trials as Topic
5
2026
1053
0.190
 Why?
Republic of Korea
6
2019
42
0.190
 Why?
Young Adult
12
2025
14105
0.190
 Why?
Forced Expiratory Volume
6
2025
449
0.180
 Why?
Pneumonectomy
2
2016
169
0.180
 Why?
Meningitis
1
2023
80
0.180
 Why?
Registries
5
2020
2385
0.180
 Why?
Spectinomycin
1
2021
2
0.180
 Why?
Isoniazid
4
2019
71
0.180
 Why?
Thorax
1
2022
50
0.180
 Why?
Lung Neoplasms
2
2012
2637
0.170
 Why?
Radiography, Thoracic
3
2017
171
0.170
 Why?
Psychometrics
1
2025
734
0.170
 Why?
Reproducibility of Results
3
2025
3409
0.170
 Why?
Comorbidity
4
2019
1658
0.170
 Why?
Cohort Studies
8
2020
5960
0.170
 Why?
Safety
1
2003
356
0.160
 Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2020
6
0.160
 Why?
Sensitivity and Specificity
5
2025
1985
0.160
 Why?
Cluster Analysis
4
2020
521
0.160
 Why?
Respiratory Therapy
1
2020
25
0.160
 Why?
Serine Proteases
1
2020
26
0.160
 Why?
Bacteriophages
1
2022
111
0.160
 Why?
Prevalence
4
2019
2834
0.160
 Why?
Child
13
2025
22633
0.150
 Why?
Area Under Curve
3
2020
330
0.150
 Why?
Nitroimidazoles
1
2019
16
0.150
 Why?
Mycobacterium fortuitum
1
2019
2
0.150
 Why?
Follow-Up Studies
5
2020
5408
0.150
 Why?
Oxazoles
1
2019
48
0.150
 Why?
Genotyping Techniques
1
2019
69
0.150
 Why?
Durable Medical Equipment
1
2019
5
0.150
 Why?
Bronchoscopy
1
2020
227
0.150
 Why?
Cost of Illness
1
2021
321
0.150
 Why?
Surveys and Questionnaires
2
2025
6048
0.140
 Why?
Genotype
6
2019
1833
0.140
 Why?
Patient Selection
1
2003
719
0.140
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2021
257
0.140
 Why?
Azabicyclo Compounds
3
2024
7
0.140
 Why?
DNA Gyrase
1
2018
12
0.140
 Why?
Aza Compounds
2
2010
13
0.140
 Why?
Respiratory System Agents
1
2018
23
0.140
 Why?
Internationality
1
2019
156
0.140
 Why?
Tertiary Care Centers
1
2019
189
0.140
 Why?
Hospitals
1
2023
730
0.140
 Why?
Disease Models, Animal
3
2025
4557
0.140
 Why?
Musculoskeletal Diseases
1
2019
88
0.140
 Why?
Hematopoietic Stem Cell Transplantation
1
2024
675
0.140
 Why?
Anti-HIV Agents
3
2016
888
0.140
 Why?
Patient Compliance
3
2011
588
0.140
 Why?
Tuberculosis Vaccines
2
2010
5
0.130
 Why?
alpha 1-Antitrypsin Deficiency
1
2018
59
0.130
 Why?
Pulmonary Medicine
1
2018
79
0.130
 Why?
Biological Specimen Banks
1
2018
102
0.130
 Why?
Salvage Therapy
1
2018
162
0.130
 Why?
Elephants
1
2017
6
0.130
 Why?
Agammaglobulinemia
1
2017
36
0.130
 Why?
Fluoroquinolones
3
2018
44
0.130
 Why?
Interferon-gamma
4
2007
784
0.130
 Why?
Databases, Genetic
1
2018
248
0.130
 Why?
Surgical Equipment
1
2016
9
0.130
 Why?
Kartagener Syndrome
1
2016
31
0.120
 Why?
Quinolines
2
2010
193
0.120
 Why?
Staphylococcal Infections
2
2018
388
0.120
 Why?
Prognosis
5
2020
4282
0.120
 Why?
Immunologic Deficiency Syndromes
1
2016
65
0.120
 Why?
Genes, Bacterial
1
2016
166
0.120
 Why?
Levofloxacin
1
2016
20
0.120
 Why?
Adrenal Cortex Hormones
1
2019
478
0.120
 Why?
Cough
3
2023
124
0.120
 Why?
Public Health
4
2016
566
0.120
 Why?
Surgical Wound Infection
1
2019
316
0.120
 Why?
Gene Expression Regulation
2
2020
2608
0.110
 Why?
Patient Outcome Assessment
1
2016
134
0.110
 Why?
Gene Expression Profiling
2
2020
1782
0.110
 Why?
Chronic Disease
3
2023
1813
0.110
 Why?
Drug Tolerance
1
2015
100
0.110
 Why?
Guidelines as Topic
1
2016
267
0.110
 Why?
Drug Evaluation, Preclinical
2
2026
194
0.100
 Why?
Antiretroviral Therapy, Highly Active
2
2007
278
0.100
 Why?
DNA Transposable Elements
2
2006
122
0.100
 Why?
Peptidoglycan
2
2026
28
0.100
 Why?
Genetic Variation
2
2021
983
0.100
 Why?
Sequence Analysis, DNA
2
2014
824
0.100
 Why?
beta-Lactamases
2
2026
51
0.100
 Why?
CD4 Lymphocyte Count
2
2004
277
0.100
 Why?
Anti-Inflammatory Agents
1
2017
474
0.100
 Why?
MicroRNAs
1
2020
701
0.100
 Why?
Computational Biology
1
2018
680
0.100
 Why?
Patient Acceptance of Health Care
2
2018
885
0.100
 Why?
Societies, Medical
4
2020
887
0.100
 Why?
Patient-Centered Care
1
2018
544
0.100
 Why?
Glucocorticoids
1
2017
535
0.090
 Why?
Gene Expression Regulation, Bacterial
1
2015
327
0.090
 Why?
Contraindications
1
2012
91
0.090
 Why?
Immunoenzyme Techniques
1
2012
200
0.090
 Why?
Glycolipids
1
2012
52
0.090
 Why?
Models, Statistical
1
2016
681
0.090
 Why?
Transcriptome
2
2015
1045
0.090
 Why?
Antibodies, Bacterial
1
2012
148
0.090
 Why?
Cytokines
2
2011
2061
0.090
 Why?
Randomized Controlled Trials as Topic
1
2018
1720
0.090
 Why?
Drug Resistance, Multiple
1
2011
25
0.090
 Why?
Immunoglobulin A
1
2012
214
0.080
 Why?
Chemical and Drug Induced Liver Injury
2
2003
139
0.080
 Why?
Drug Interactions
1
2012
398
0.080
 Why?
Pulmonary Disease, Chronic Obstructive
2
2018
920
0.080
 Why?
Debridement
1
2011
86
0.080
 Why?
Kaplan-Meier Estimate
3
2019
965
0.080
 Why?
Virulence
1
2011
278
0.080
 Why?
Hospitals, General
2
2014
26
0.080
 Why?
Metagenomics
2
2021
181
0.080
 Why?
Animals
8
2025
38058
0.080
 Why?
Case-Control Studies
3
2020
3604
0.080
 Why?
Respiratory Tract Infections
1
2014
397
0.080
 Why?
Hepatitis, Viral, Human
1
2009
20
0.080
 Why?
Netherlands
2
2012
82
0.080
 Why?
Bacteriological Techniques
1
2009
68
0.070
 Why?
Mice
5
2025
18339
0.070
 Why?
Forkhead Transcription Factors
2
2007
202
0.070
 Why?
Confidence Intervals
2
2015
333
0.070
 Why?
Interleukins
2
2007
248
0.070
 Why?
Clinical Decision-Making
2
2026
359
0.070
 Why?
Lung Transplantation
1
2012
338
0.070
 Why?
Vitamins
1
2010
178
0.070
 Why?
Early Diagnosis
1
2009
249
0.070
 Why?
Proportional Hazards Models
2
2019
1325
0.070
 Why?
Radiography
2
2008
844
0.070
 Why?
RNA, Ribosomal, 23S
2
2018
12
0.070
 Why?
Interleukin-9
1
2007
12
0.070
 Why?
Child, Preschool
4
2016
11787
0.070
 Why?
Logistic Models
3
2019
2117
0.070
 Why?
Hospitalization
1
2018
2433
0.070
 Why?
Survival Analysis
2
2016
1382
0.070
 Why?
Reagent Kits, Diagnostic
1
2007
34
0.070
 Why?
Interleukin-12 Subunit p40
1
2007
9
0.060
 Why?
Polysaccharides, Bacterial
1
2007
67
0.060
 Why?
Pneumonia, Pneumococcal
1
2007
47
0.060
 Why?
Congresses as Topic
2
2020
221
0.060
 Why?
Th1 Cells
1
2007
139
0.060
 Why?
Polymorphism, Single Nucleotide
3
2021
2145
0.060
 Why?
Vitamin D
1
2010
400
0.060
 Why?
Survivors
1
2010
520
0.060
 Why?
Liver Function Tests
2
2003
106
0.060
 Why?
Interleukin-8
1
2007
271
0.060
 Why?
Age Factors
3
2019
3333
0.060
 Why?
Japan
1
2026
143
0.060
 Why?
Monte Carlo Method
1
2026
155
0.060
 Why?
Keratosis
1
2025
16
0.060
 Why?
Regression Analysis
1
2008
1003
0.060
 Why?
Hydrotherapy
1
2005
7
0.060
 Why?
Penicillin-Binding Proteins
1
2024
2
0.060
 Why?
Bacterial Load
1
2025
67
0.060
 Why?
Immunosuppressive Agents
1
2009
846
0.050
 Why?
Coinfection
2
2018
141
0.050
 Why?
Microbial Viability
1
2025
90
0.050
 Why?
Antirheumatic Agents
1
2007
304
0.050
 Why?
Anti-Retroviral Agents
1
2007
250
0.050
 Why?
Cost-Benefit Analysis
2
2024
634
0.050
 Why?
Whole Genome Sequencing
1
2025
182
0.050
 Why?
Biopsy
2
2005
1075
0.050
 Why?
Mycobacterium xenopi
2
2014
2
0.050
 Why?
Streptomycin
1
2003
18
0.050
 Why?
Respiratory Function Tests
2
2016
547
0.050
 Why?
Delphi Technique
1
2026
329
0.050
 Why?
Molecular Docking Simulation
1
2024
124
0.050
 Why?
Carrier State
1
2004
79
0.050
 Why?
Influenza, Human
1
2009
616
0.050
 Why?
Multicenter Studies as Topic
1
2025
405
0.050
 Why?
Dust
1
2023
102
0.050
 Why?
Pseudomonas Infections
2
2016
221
0.050
 Why?
Staphylococcus aureus
2
2018
455
0.050
 Why?
Medicare
2
2019
886
0.050
 Why?
Homosexuality, Male
1
2004
222
0.050
 Why?
Substance Abuse, Intravenous
1
2004
128
0.050
 Why?
Tumor Necrosis Factor-alpha
1
2007
1217
0.050
 Why?
Predictive Value of Tests
2
2007
2115
0.050
 Why?
Databases, Factual
2
2019
1486
0.050
 Why?
Transplant Recipients
1
2024
180
0.040
 Why?
Los Angeles
1
2002
76
0.040
 Why?
Survival Rate
1
2007
2089
0.040
 Why?
Lactams
1
2021
28
0.040
 Why?
Drug Costs
1
2003
116
0.040
 Why?
Amoxicillin
1
2022
35
0.040
 Why?
Cross-Sectional Studies
3
2025
5868
0.040
 Why?
Phenotype
2
2021
3162
0.040
 Why?
Bacterial Proteins
1
2007
955
0.040
 Why?
Clone Cells
1
2021
266
0.040
 Why?
Carboxypeptidases
1
2020
12
0.040
 Why?
Real-Time Polymerase Chain Reaction
1
2021
341
0.040
 Why?
Leukocyte Elastase
1
2020
75
0.040
 Why?
Water
1
2023
469
0.040
 Why?
Ambulatory Care
1
2005
600
0.040
 Why?
Gene Ontology
1
2020
53
0.040
 Why?
Multivariate Analysis
1
2003
1539
0.040
 Why?
Chimera
1
2019
61
0.040
 Why?
Medication Adherence
1
2024
539
0.040
 Why?
United States Food and Drug Administration
1
2020
203
0.040
 Why?
Neutrophils
1
2025
1134
0.040
 Why?
Public Health Surveillance
1
2019
83
0.040
 Why?
Stem Cells
1
2023
626
0.040
 Why?
Cross-Over Studies
1
2021
601
0.040
 Why?
Mice, Inbred BALB C
1
2021
1253
0.040
 Why?
Molecular Diagnostic Techniques
1
2019
104
0.040
 Why?
Risk Assessment
2
2019
3671
0.040
 Why?
Population Surveillance
1
2002
485
0.040
 Why?
Meat
1
2019
93
0.030
 Why?
Ribosomal Proteins
1
2018
91
0.030
 Why?
Prosthesis-Related Infections
1
2019
99
0.030
 Why?
Insurance Claim Review
1
2018
83
0.030
 Why?
Symptom Assessment
1
2019
137
0.030
 Why?
Gene Expression
2
2016
1490
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
2
2011
851
0.030
 Why?
Gene Regulatory Networks
1
2020
318
0.030
 Why?
International Cooperation
1
2018
198
0.030
 Why?
Drug Monitoring
2
2016
395
0.030
 Why?
Animals, Zoo
1
2017
15
0.030
 Why?
Methyltransferases
1
2017
74
0.030
 Why?
Otitis
1
2016
9
0.030
 Why?
Pseudomonas
1
2016
33
0.030
 Why?
Immunoglobulins
1
2017
160
0.030
 Why?
Drug Resistance, Microbial
1
2016
69
0.030
 Why?
Delivery of Health Care
1
2023
947
0.030
 Why?
Micronesia
1
2016
7
0.030
 Why?
Mycobacterium chelonae
1
2016
8
0.030
 Why?
Spirometry
1
2016
231
0.030
 Why?
Host-Pathogen Interactions
1
2019
371
0.030
 Why?
Multiple Pulmonary Nodules
1
2016
21
0.030
 Why?
Vital Capacity
1
2016
290
0.030
 Why?
Injections, Intravenous
1
2016
200
0.030
 Why?
Body Temperature Regulation
1
2016
108
0.030
 Why?
Needs Assessment
1
2018
404
0.030
 Why?
Bronchi
1
2017
267
0.030
 Why?
Drug Combinations
1
2016
390
0.030
 Why?
Uganda
1
2015
93
0.030
 Why?
Leukocytes, Mononuclear
2
2007
573
0.030
 Why?
Rhinitis
1
2016
171
0.030
 Why?
Fibrosis
1
2017
548
0.030
 Why?
Gastroesophageal Reflux
1
2016
236
0.030
 Why?
Research Design
1
2020
1135
0.030
 Why?
Insurance, Health
1
2016
302
0.030
 Why?
Sinusitis
1
2016
228
0.030
 Why?
Sequence Homology, Nucleic Acid
1
2013
157
0.030
 Why?
False Positive Reactions
1
2014
121
0.030
 Why?
RNA, Messenger
2
2015
2832
0.020
 Why?
Consensus
1
2016
488
0.020
 Why?
Mycobacterium avium
1
2013
21
0.020
 Why?
Greece
1
2012
9
0.020
 Why?
DNA, Ribosomal Spacer
1
2012
8
0.020
 Why?
Mycolic Acids
1
2012
7
0.020
 Why?
Bacterial Typing Techniques
1
2012
44
0.020
 Why?
Iran
1
2012
44
0.020
 Why?
Self Report
1
2017
872
0.020
 Why?
Geography
1
2013
203
0.020
 Why?
Italy
1
2012
113
0.020
 Why?
Sweden
1
2012
111
0.020
 Why?
DNA-Directed RNA Polymerases
1
2012
63
0.020
 Why?
Cerebrospinal Fluid
1
2012
88
0.020
 Why?
Species Specificity
1
2013
574
0.020
 Why?
Developing Countries
2
2005
318
0.020
 Why?
Heat-Shock Proteins
1
2012
138
0.020
 Why?
Protein Array Analysis
1
2011
56
0.020
 Why?
Microspheres
1
2011
142
0.020
 Why?
Drug Discovery
1
2012
155
0.020
 Why?
Pseudomonas aeruginosa
1
2014
356
0.020
 Why?
Bone Marrow Cells
1
2012
320
0.020
 Why?
Demography
1
2011
288
0.020
 Why?
Adaptation, Physiological
1
2015
570
0.020
 Why?
In Vitro Techniques
1
2012
1047
0.020
 Why?
Body Mass Index
1
2019
2438
0.020
 Why?
Evolution, Molecular
1
2014
514
0.020
 Why?
Referral and Consultation
1
2016
851
0.020
 Why?
Postoperative Care
1
2012
288
0.020
 Why?
Hepatitis, Chronic
1
2009
5
0.020
 Why?
RNA, Ribosomal, 16S
1
2012
558
0.020
 Why?
Preoperative Care
1
2012
379
0.020
 Why?
Smoking
1
2016
1472
0.020
 Why?
Age Distribution
1
2010
403
0.020
 Why?
Fatty Acids
1
2012
450
0.020
 Why?
Sex Distribution
1
2010
386
0.020
 Why?
Pleural Diseases
1
2009
23
0.020
 Why?
Anxiety
1
2016
1109
0.020
 Why?
Transcription, Genetic
1
2015
1496
0.020
 Why?
Age of Onset
1
2010
551
0.020
 Why?
Vulnerable Populations
1
2009
177
0.020
 Why?
Molecular Sequence Data
1
2012
2930
0.020
 Why?
False Negative Reactions
1
2007
60
0.020
 Why?
Lymphatic Diseases
1
2007
20
0.020
 Why?
Urinalysis
1
2007
80
0.020
 Why?
Continuity of Patient Care
1
2009
291
0.020
 Why?
Depression
1
2016
1558
0.020
 Why?
Bone Diseases
1
2007
61
0.020
 Why?
Forced Expiratory Flow Rates
1
2006
10
0.020
 Why?
Clinical Laboratory Techniques
1
2007
96
0.010
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2010
370
0.010
 Why?
Longitudinal Studies
1
2014
2947
0.010
 Why?
Africa
1
2006
116
0.010
 Why?
Lung Diseases, Interstitial
1
2012
660
0.010
 Why?
Infection Control
1
2007
172
0.010
 Why?
Skin Diseases
1
2007
149
0.010
 Why?
C-Reactive Protein
1
2007
416
0.010
 Why?
Asthma
1
2016
1767
0.010
 Why?
India
1
2005
218
0.010
 Why?
Up-Regulation
1
2007
851
0.010
 Why?
Virus Latency
1
2005
90
0.010
 Why?
Anti-Infective Agents
1
2007
242
0.010
 Why?
Dendritic Cells
1
2007
499
0.010
 Why?
Quality of Health Care
1
2009
691
0.010
 Why?
Wounds and Injuries
1
2012
956
0.010
 Why?
Cost Savings
1
2004
86
0.010
 Why?
Diagnostic Techniques, Respiratory System
1
2003
5
0.010
 Why?
Pleura
1
2003
28
0.010
 Why?
HIV Seronegativity
1
2003
29
0.010
 Why?
Costs and Cost Analysis
1
2004
219
0.010
 Why?
Pleural Effusion
1
2003
60
0.010
 Why?
HIV Seropositivity
1
2003
119
0.010
 Why?
Severity of Illness Index
1
2010
2925
0.010
 Why?
Chi-Square Distribution
1
2003
529
0.010
 Why?
Infant
1
2016
10034
0.010
 Why?
Clinical Protocols
1
2003
282
0.010
 Why?
Mice, Inbred C57BL
1
2012
5992
0.010
 Why?
Health Policy
1
2004
400
0.010
 Why?
Data Interpretation, Statistical
1
2003
372
0.010
 Why?
Hypertension, Pulmonary
1
2012
1980
0.010
 Why?
Models, Theoretical
1
2004
582
0.010
 Why?
Rural Population
1
2005
650
0.010
 Why?
Liver
1
2002
1887
0.010
 Why?
Daley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (471) concept(s)
_
Co-Authors Expand Description
See all (34) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)